Carlyle to acquire Baxter's Vantive kidney care segment for $3.8B

Baxter International Inc. signed a definitive agreement to divest its Kidney Care segment (Vantive) to funds managed by Carlyle for $3.8 billion. Baxter will receive approximately $3.5 billion in cash.

“Baxter International Inc. and funds managed by global investment firm Carlyle today announced that they have signed a definitive agreement under which Carlyle is to acquire Baxter’s Kidney Care segment, to be named Vantive, for $3.8 billion.”carlyle.com

• 1 source
• carlyle.comBaxter Announces Definitive Agreement to Divest Its Vantive Kidney Care Segment to Carlyle For $3.8 Billion | CarlyleAug 13, 2024

Summarized from public sources; check the original articles before acting on it.